Silymarin in the management of liver enzyme activity in steatohepatitis: a case report
Metabolic-associated fatty liver disease (MAFLD) is the main condition of altered liver enzymes worldwide. With a constant increase in liver hospitalizations, MAFLD is the second cause of cirrhosis and soon will be the first cause of liver transplantation. Early recognition of MAFLD and a personaliz...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioExcel Publishing Ltd
2023-04-01
|
| Seria: | Drugs in Context |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.drugsincontext.com/silymarin-in-the-management-of-liver-enzyme-activity-in-steatohepatitis-a-case-report/ |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|